Numerous US Approvals Received By Lupin Following 278% Quarterly Profits Raise

Analysts Posit That Lupin Has Peaked For The Year

 
• By Chloe Kent

Lupin has announced a number of drug approvals in the US, as well as a biosimilar partnership in the Middle East and the launch of a novel fixed-dose triple combination drug in its native Indian market.

FDA approved concept
Lupin has recieved FDA approval for five different generic drugs • Source: Shutterstock

More from Generics

More from Products